Shirasu, H., Ono, A., Omae, K., Nakashima, K., Omori, S., Wakuda, K., . . . Takahashi, T. (2018). CYFRA 21-1 predicts the efficacy of nivolumab in patients with advanced lung adenocarcinoma. SAGE Publishing.
Chicago Style (17th ed.) CitationShirasu, Hiromichi, et al. CYFRA 21-1 Predicts the Efficacy of Nivolumab in Patients with Advanced Lung Adenocarcinoma. SAGE Publishing, 2018.
MLA (9th ed.) CitationShirasu, Hiromichi, et al. CYFRA 21-1 Predicts the Efficacy of Nivolumab in Patients with Advanced Lung Adenocarcinoma. SAGE Publishing, 2018.
Warning: These citations may not always be 100% accurate.